Delivery Order SPE2DB20D9214-SPE2DB25FD4XB
Award Date 8/14/25
Potential Completion Date 9/5/25
Potential Value $5.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $5,263.24 for Mitosol 0.2 mg kits. The contract, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,947.40 on September 9, 2025, for the supply of Mitosol 0.2 mg kits. The contract, which carries no set-aside designation, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499.999 billion and extending through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,631.60 on July 22, 2025, for Mitosol 0.2 mg kits. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the broader...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,263.24 by the Defense Logistics Agency on August 20, 2025, for the supply of Mitosol 0.2 mg kits. The delivery order carries an ultimate completion date of September 11, 2025, and no set-aside designation was used in the procurement. This award represents a continuation of the company's established role as a critical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,315.80 by the Medical Supply Chain division of the Defense Logistics Agency on July 25, 2025. The delivery order, which is expected to be completed by August 14, 2025, covers the supply of Mitosol 0.2mg kits in quantities of three units. This award was issued without a set-aside designation, and the place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $5,263.24 to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits, with an ultimate completion date of August 8, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract employs firm fixed-price pricing and represents a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,894.80 on September 15, 2025, for Mitosol 0.2 mg kits. This firm fixed-price delivery order, which must be completed by October 6, 2025, was issued by the Medical Supply Chain, a defense-focused federal agency. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete openly in the federal procurement...
- The Defense Logistics Agency awarded a $3,947.40 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mitosol 0.2 mg kits. The contract, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, utilizes a firm fixed-price structure and carries no set-aside designation. This delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $15,789.60 to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The award was issued on May 12, 2025, with an ultimate completion date of June 3, 2025, and carries no set-aside designation. This delivery order falls under DMS...
- The Defense Logistics Agency (DLA) under the Medical Supply Chain issued a delivery order valued at $7,894.80 to DMS Pharmaceutical Group Inc. for Mitosol 0.2 mg kits. The award, made on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA valued at approximately $500 million through...